Viewing Study NCT04195958


Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2026-01-11 @ 12:05 PM
Study NCT ID: NCT04195958
Status: TERMINATED
Last Update Posted: 2022-03-15
First Post: 2019-12-09
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma
Sponsor: Genentech, Inc.
Organization: